Enter your information to understand your Anti-TPO levels.

The History of Anti-TPO

The condition behind this antibody test was first described in 1912 by Japanese surgeon Hakaru Hashimoto, who documented a distinctive pattern of chronic thyroid inflammation in four patients, a disease now bearing his name, though at the time no one understood what was actually causing it or why it seemed to run in certain families. It wasn't until 1956 that British researchers Deborah Doniach and Ivan Roitt, working at Middlesex Hospital in London, discovered that patients with this condition carried antibodies attacking their own thyroid tissue, launching the entire field of organ-specific autoimmune disease almost overnight. What they initially called a "microsomal antibody," based on the cell fraction it reacted with, was eventually identified decades later as targeting a specific thyroid enzyme, leading to the more precise modern name still used today: thyroid peroxidase antibody, or anti-TPO.

What Anti-TPO Actually Is

Thyroid peroxidase is an enzyme found inside thyroid gland cells that plays an essential role in producing thyroid hormone, specifically by attaching iodine atoms onto a protein scaffold during hormone synthesis, a critical step called organification that simply cannot happen without it. Anti-TPO antibodies form when the immune system mistakenly identifies this enzyme as a foreign threat and begins attacking it, gradually damaging thyroid tissue and impairing hormone production over months or years of ongoing exposure. Their presence is one of the strongest and most common markers of autoimmune thyroid disease, appearing in the large majority of people with Hashimoto's thyroiditis and in a substantial share of people with Graves' disease, even though these two conditions cause opposite hormonal problems — one underactive, one overactive.

How Anti-TPO Is Measured

Early testing relied on relatively crude techniques like hemagglutination, in which red blood cells coated with thyroid antigen would visibly clump together in the presence of antibodies, giving only a rough yes-or-no result rather than a precise numeric value. Laboratories later moved to radioimmunoassay in the 1970s and 1980s for meaningfully better sensitivity and reproducibility, and today virtually all clinical labs use automated chemiluminescent immunoassays, in which a light-emitting chemical reaction is triggered in direct proportion to how much antibody binds a purified thyroid peroxidase antigen fixed to a testing surface. This modern approach delivers a precise numeric result within hours rather than the days that earlier methods typically required to complete.

Scientists Behind the Science

Hakaru Hashimoto's original 1912 clinical description gave the disease its lasting name, but it was Deborah Doniach and Ivan Roitt's serological work more than four decades later that revealed the true underlying autoimmune mechanism, fundamentally changing how physicians understood thyroid disease at a biological level. Their discovery ran parallel to important experimental work by American researchers Ernst Witebsky and Noel Rose, who around the same period demonstrated that immunizing rabbits with thyroid tissue could reliably trigger an equivalent autoimmune thyroiditis, providing crucial experimental proof that the immune system truly could be turned against the body's own healthy organs. Together, this combined research helped establish the broader scientific criteria still used today for recognizing and formally defining autoimmune diseases in general, well beyond just the thyroid gland.